IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
IPO Detail
IPO Information
Financial
Financial Report
Peer Comparison
Performance
Performance Report
Ambey Laboratories IPO listing price is ₹ 89.25, issue price is ₹ 68.00, and currently trading at ₹ 40.75 as on June 12, 2025. Ambey Laboratories IPO performance is show below with latest CAGR.
*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.
Ambey Laboratories IPO is a Book Building listing on NSE EMERGE exchange. The company is based in New Delhi and caters to Chemical - Pesticides sector. Fast Track Finsec is the merchant banker of Ambey Laboratories IPO. It is a SME IPO which filed its Draft Red Herring Prospectus (DRHP) on 2nd February 2024.
Ambey Laboratories IPO offer price is ₹ 68.00 and got listed at ₹ 89.25. Read Ambey Laboratories IPO details mentioned above.The IPO of Ambey Laboratories Limited was listed on 11th July 2024. As of today, Ambey Laboratories IPO is trading at ₹ 40.75, compared to the previous day’s close of ₹ 39.50. Read the report above for detailed IPO performance.
The issue price of Ambey Laboratories IPO was ₹ 68.00 per equity share.
Ambey Laboratories IPO was listed at ₹89.25 on the stock exchange on 11th July 2024. The listing price is the price at which the shares started trading on the stock exchange after the IPO was completed.
As of June 12, 2025, the current market price of Ambey Laboratories IPO is ₹ 40.75.
The 52-week high for Ambey Laboratories IPO is [●], while the 52-week low is [●]. These figures reflect the stock’s highest and lowest trading prices in the past one year from the current date.
The Ambey Laboratories IPO listed at ₹ 89.25 against the issue price of ₹ 68.00 per equity share, showing a listing day gain/loss of 21.25 (31.25%) , calculated by comparing the listing price to the issue price on the first day of trading.
The Ambey Laboratories IPO stock moved from its listing price of ₹ 89.25 to the current price of ₹40.75 per equity share, reflecting a change of -54.34% per share, calculated by subtracting the listing price from the current market price (CMP) as of today.
Based on Ambey Laboratories IPO issue date of 11th July 2024 and CMP of ₹40.75, the estimated CAGR is approximately -42.38%.
*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.
Face
Value :
₹ 10
Issue
Price :
₹ 68.00
Listing Price :
₹ 89.25
Previous Day Closing
₹ 39.50
Ambey Laboratories IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on Ambey Laboratories Financial Review Page
Merchant Banker(s) of Ambey Laboratories IPO: Fast Track Finsec Private Limited
Ambey Laboratories IPO subscription was 173.18 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Ambey Laboratories IPO listed at a listing price of 89.25 against the offer price of 68.00.
The current market price of Ambey Laboratories is 40.75.
Why Us?
